Vitamin B12

What Vitamin B12 Measures

B12 is required for DNA synthesis, red blood cell production, and nerve myelination. Severe deficiency causes megaloblastic anemia and irreversible neurologic damage. Mild-to-moderate deficiency is common and often missed because the lab "normal" range starts at 232 pg/mL - but symptoms (fatigue, paresthesias, brain fog) can appear well above that threshold.

B12 is found almost exclusively in animal foods. Vegetarians and vegans need supplementation. Long-term metformin use depletes B12 absorption - ~30% of metformin users have low B12 after 5+ years. PPI users (omeprazole, etc) also have impaired absorption.

What Affects This Biomarker

B12 is influenced by: dietary intake (animal foods only - vegetarian/vegan diets without supplementation deplete it), absorption (intrinsic factor, healthy stomach acid required), age (absorption declines), pernicious anemia (autoimmune destruction of intrinsic factor), and pharmacologic agents - metformin lowers absorption; PPIs and H2 blockers lower absorption; supplementation (oral 500–1000 mcg daily, sublingual, or injection) restores reliably.

In the Context of Peptide Protocols

Test annually on metformin or PPI use, every 2–3 years otherwise. If low (<400) or borderline with symptoms, supplement methylcobalamin 1000 mcg daily, retest at 12 weeks. Pair with homocysteine - elevated homocysteine with low-normal B12 suggests functional deficiency. Critical to monitor on long-term GLP-1 + metformin combos.

Deep Dive

What serum B12 actually measures, and why "normal" can mislead

A standard serum B12 test measures total cobalamin in the blood, but most of that pool is not usable by your cells. Roughly 70-90% of circulating B12 is bound to haptocorrin (holo-haptocorrin), a transport protein that delivers essentially nothing to tissues. Only the fraction bound to transcobalamin, called **holotranscobalamin** or "active B12," is actually taken up by cells, and that active fraction is often just 10-30% of the total. This is why a serum value sitting in the 300-400 pg/mL range can look reassuring while the metabolically available supply is already thin.

The two cobalamin-dependent enzymes live inside the cell, so the blood number is a proxy, not the endpoint. B12 works as **methylcobalamin**, the cofactor for methionine synthase that recycles homocysteine back to methionine, and as **adenosylcobalamin**, the cofactor for methylmalonyl-CoA mutase in the mitochondria. When either enzyme runs short of cofactor, its upstream substrate accumulates, and those substrates are what functional testing detects.

The functional markers that flag deficiency first

Two intermediates rise before serum B12 falls into the clearly deficient range:

- **Methylmalonic acid (MMA)** is the most specific marker of intracellular B12 status. When adenosylcobalamin is scarce, methylmalonyl-CoA cannot be converted onward and MMA accumulates in blood and urine. Elevated MMA alongside a low-normal serum B12 is strong evidence of true tissue deficiency. - **Homocysteine** rises when methionine synthase lacks methylcobalamin. It is sensitive but not specific, since folate deficiency, B6 deficiency, renal impairment, and hypothyroidism also raise it. That non-specificity is exactly why this marker is best read together with B12.

The pattern many optimization-minded clinicians describe: when serum B12 sits in the 200-400 pg/mL gray zone with symptoms present, MMA is often the tiebreaker. A normal MMA argues against meaningful deficiency; an elevated MMA argues for it regardless of the serum number. Reynolds' 2006 Lancet Neurology review of B12 and the nervous system is a useful anchor for how neurologic injury can precede any change in the blood count.

Why the optimal target sits well above the lab floor

The lab lower limit near 232 pg/mL was set to catch overt megaloblastic anemia, not to protect nerve function. Paresthesias, gait changes, and cognitive fog are documented in people whose serum B12 sits in the 200-350 pg/mL band. Several countries use higher thresholds: Japan and parts of Europe commonly flag deficiency below roughly 400 pmol/L, which is about 540 pg/mL, rather than the far lower United States cutoff. Unit conversion helps here, since pg/mL multiplied by 0.738 gives pmol/L. A 500-900 pg/mL optimization target reflects a margin above the level where functional markers begin to drift, not a claim that higher is always better.

Testing pitfalls and timing

Serum B12 is unusually easy to misread:

- **Recent supplementation falsely elevates it.** A single high-dose oral tablet or injection can push serum levels up for days to weeks while tissue status is unchanged. To read true status, a sample drawn before restarting supplements, or interpreted alongside MMA, tends to be more informative. - **High-dose biotin interferes with the assay.** Many B12 immunoassays use biotin-streptavidin chemistry, and biotin supplements common in hair, skin, and nail products can skew the result. The FDA issued a safety communication on biotin assay interference; holding biotin for 48-72 hours before the draw is commonly recommended to avoid it. - **Folate can mask the anemia.** High folate intake corrects the megaloblastic blood picture while neurologic damage from B12 deficiency can continue silently, so a normal CBC does not rule B12 deficiency out. - **Falsely high B12** appears in liver disease, heavy alcohol use, and myeloproliferative disorders, where haptocorrin is elevated. A high number in those settings is not reassurance. - **Nitrous oxide** irreversibly oxidizes the cobalt core of B12 and inactivates methionine synthase, so repeated recreational use, or anesthesia in someone already low, can precipitate deficiency that a single serum draw may miss.

Metformin, GLP-1, and protocol tracking context

Metformin does not merely lower the B12 number cosmetically. It interferes with the calcium-dependent absorption of the B12-intrinsic factor complex in the terminal ileum. The long-running Diabetes Prevention Program Outcomes Study analysis (Aroda et al., 2016) found that years of metformin use were associated with a higher risk of biochemical B12 deficiency. Some data suggest oral calcium can partly counter the absorption block, though supplementing B12 directly is the more reliable route to discuss with a clinician.

This matters most for the fast-growing group running GLP-1 therapy alongside metformin. GLP-1 receptor agonists suppress appetite and cut total food intake, which reduces dietary B12 delivery at the same moment metformin blunts absorption. On that combination, tracking B12 with homocysteine on a regular cadence gives a cleaner functional read than either number alone.

Forms of B12 and what reliably restores levels

Not all B12 on the shelf behaves the same. Cyanocobalamin is the most stable and best studied, inexpensive and effective for most people. Methylcobalamin and adenosylcobalamin are the active coenzyme forms some prefer. Hydroxocobalamin, the usual injectable, has a longer half-life. Importantly, about 1% of an oral dose is absorbed by passive diffusion independent of intrinsic factor, which is why high-dose oral B12 can restore levels even in pernicious anemia. Whatever the form, retesting after roughly 12 weeks, ideally with MMA or homocysteine rather than serum B12 alone, is how you confirm the supply actually reached the cells. What to test, which form, and how often are decisions to make with your clinician.

Conditions That Track Vitamin B12

Frequently Asked Questions

Where This Fits in Your Panel

Vitamin B12 is one marker on a fuller panel. The Peptide Blood Work Checklist lays out the complete baseline panel, what to add by protocol type, and when to retest.

Upload any lab PDF and MyProtocolStack maps your values to Vitamin B12 and 40+ other biomarkers. StackAI interprets the trend in context of your protocol.